An observational study in The Results of Total Hip Arthroplasty in Crowe Type 4 Dysplastic Hips, sponsored by Private Ortopedia Hospital, Seyhan Adana. Completed at 1 site in Turkey. Per ClinicalTrials.gov, last updated 2021-04-08.
Sponsored by Private Ortopedia Hospital, Seyhan Adana · Observational
Total hip arthroplasty (THA) performed for developmental dysplasia of the hip (DDH) is a technically difficult procedure with a high complication rate, especially in the presence of completely dislocated hips. This study aimed to evaluate the results of at least 10 years of follow-up results of cementless, ceramic-on-ceramic (CoC) total hip arthroplasty performed with transverse subtrochanteric osteotomy in Crowe type 4 hips.
We reviewed retrospectively 67 hips of 50 patients which underwent CoC, cementless THA with transverse subtrochanteric osteotomy between 2008 and 2011. Clinical and radiological data of the hips were examined. Clinical results were evaluated using the Harris Hip Score (HHS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).
This is the only study on the registry with Private Ortopedia Hospital, Seyhan Adana as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Crowe type 4 developmental dysplasia of the hip patient
Crowe type 4 developmental dysplasia of the hip
Exclusion Criteria:
Primary Coxarthrosis
Total hip arthroplasty in Crowe type 4 developmental dysplasia of the hip.
Clinical results
Haris Hip Score
Time frame: minimum 10 year follow-up
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.